SAT0539 Differential profile of endogenous peptides detected by targeted proteomics in hip and knee cartilage secretomes from osteoarthritis patients. (15th June 2017)

• Record Type: Journal Article
• Authors: Fernandez-Puente, P; Gonzalez-Rodriguez, L; Calamia, V; Lourido, L; Camacho, M; Ruiz-Romero, C; Blanco, FJ
• Is Part Of: Annals of the rheumatic diseases. Volume 76(2017)Supplement 2
• Page Start: 980
• Page End: 980
• Publication Date: 2017-06-15
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2017-eular.6185
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Peptidomics can be defined as the comprehensive, qualitative and quantitative study of all native peptides in a sample in a defined space at a defined time under defined biological conditions. LC-MS/MS targeted proteomics have been used to identify and quantify candidate molecular biomarkers in diverse range of samples, including cells, tissues, serum/plasma, and other types of body fluids. Objectives: In the present work, we have developed a targeted method to detect a panel of endogenous peptides that were identified as released from human healthy (N) and/or osteoarthritic (OA) hip and knee cartilage. Secretomes were obtained separately from the wounded (WZ) and unwounded (UZ) zones of OA cartilage. The enrichment of endogenous peptides was achieved by ultrafiltration and solid phase extraction (SPE). After peptide extraction, the different peptide profiles of these secretomes were relative quantified by target proteomics. Methods: Proteins secreted from human articular cartilage (secretomes) were obtained by culture of tissue explants [1]. The enrichment of endogenous peptides was standardized using ultrafiltration procedures and solid phase extraction with reversed phase (C18) resins. A method for the targeted identification and relative quantitation of endogenous peptides by Multiple Reaction Monitoring (MRM)-mass spectrometry was developed employing cartilage secretome samples, and then applied on synovial fluid and serum. The peptides were separated by nano-LC coupled to a 5500 QTRAP mass spectrometer using stable isotope-labeled (SI) peptides as an internal control. Peptide identifications were searched using the ProteinPilot program. Data analysis was performed using the Skyline software. Results: 23 endogenous peptides belonging to 9 proteins related with OA, as Cartilage Oligemeric Matrix Protein (COMP), Cartilage Intermediate Layer Protein (CILP), Prolargin (PRELP), Dermcidin (DCD), Fibronectin (FINC) and Glia Derived Nexin (GDN) among others, were differentially detected and relatively quantified in the cartilage secretomes. Some of the endogenous peptides belonging to COMP, FINC and GDN were found with a significant high release in the UZ of hip cartilage, however in knee cartilage the release is higher in the WZ. On the other hand, certain peptides belonging to proteins like CILP or PRELP were found to be mostly increased in the UZ of both hip and knee OA cartilages when compared to healthy tissue. Conclusions: A panel of endogenous peptides has been identified in articular cartilage, which are differentially released between OA and healthy patients, as well as between knee and hip OA patients. These endogenous peptides may be potential biomarkers to differentiate osteoarthritis from hip and knee. Our targeted proteomics approach would be widely applicable to quantify low abundant peptides of interest in complex biological samples as synovial fluid and serum in order to unravel their putative biomarker value for osteoarthritis. References: Lucía Lourido et al. "Quantitative Proteomic Profiling of Human Articular Cartilage Degradation in Osteoarthritis". J Proteome Res. 2014 Dec 5;13(12):6096–106. Disclosure of Interest: None declared